Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +285.3% | +1167.1% | 3 / 3 | +42.9% | -1.05 pp | +0.98 pp | +18.6% | 0.49 | 1.91 | 524 | +42,9% | 8,2 | +285,3% | 1.91 | 2.12 | −10,0% |
| Pts | 12 | 12 | 12 | 12 | 4 | 8 | 8 | 12 | 8 | |||||||
Valuation annotation:Price: 10.000 (close price on 2026-10-19)EPS (TTM): 5.240
Financial charts
1.Revenue & growth
VND bn524Q2/26
1.Revenue & growth
VND bn524Q2/26
2.Profit & growth
VND bn8,16Q2/26
3.Profit mix (Penman)
VND bn112Q2/26
4.Margins & cost structure
%2.2%Q2/26
5.Returns & cash cycle
% · days-12.7%Q2/26
6.Earnings quality & cash
VND bn44,3Q2/26
7.Asset structure
VND bn945Q2/26
8.Funding & debt health
VND bn · times945Q2/26
9.Revenue backlog
VND bn1,44Q2/26
10.Valuation
times · %1,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %400Q2/26
Adjusted EPS growth, latest quarter
285%
Average adjusted EPS growth, 3 quarters
162%
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26